Biomea Fusion Inc (US: BMEA) — Healthcare · Share Price, Chart & Market Data
About: Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral covalent small molecule drugs to treat patients with metabolic diseases in the United States. It's lead product candidate icovamenib, an orally bioavailable, potent, and covalent inhibitor of menin, a ubiquitously expressed scaffold protein that functions in histone modification and epigenetic gene regulation to impact multiple cellular processes including cell cycle control, apoptosis, and DNA damage repair. Biomea Fusion, Inc. was incorporated in 2017 and is headquartered in San Carlos, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.89 (+1.07%)
BMEABiomea Fusion Inc
Loading watchlist status…
Trade BMEA now
Biomea Fusion Inc share price
BMEA price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 9:22 am GMT+0
BMEA price performance
-1.047%
5D
43.182%
1M
41.045%
YTD
-15.625%
1Y
BMEA price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 9:22 am GMT+0
BMEA details
BMEA Market Signals